Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Literature
1.
Xia X, Wu J, Zhang J. The effect of online versus hospital warfarin management on patient outcomes: a systematic review and meta-analysis. Int J Clin Pharm. 2018;40(6):1420–9.CrossRef
2.
Prochaska JH, Göbel S, Keller K, Coldewey M, Ullmann A, Lamparter H, et al. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service—results from the prospective, multi-center, observational cohort study thrombEVAL. BMC Med. 2015;13:14.CrossRef
3.
Salvador CH, Ruiz-Sanchez A, González de Mingo MA, Carmona Rodríguez M, Carrasco MP, Sagredo PG, et al. Evaluation of a telemedicine-based service for the follow-up and monitoring of patients treated with oral anticoagulant therapy. IEEE Trans Inf Technol Biomed. 2008;12(6):696–706.CrossRef
4.
Lin SW, Kang WY, Lin DT, Lee J, Wu FL, Chen CL, Tseng YJ. Comparison of warfarin therapy clinical outcomes following implementation of an automated mobile phone-based critical laboratory value text alert system. BMC Med Genomics. 2014;7(Suppl 1):S13.CrossRef
Metadata
Title
Letter to the editor for a published article titled “The effect of online versus hospital warfarin management on patient outcomes: a systematic review and meta-analysis”
Authors
Teerapon Dhippayom
Beth Devine
Publication date
01-02-2020
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2020
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00947-8

Other articles of this Issue 1/2020

International Journal of Clinical Pharmacy 1/2020 Go to the issue

Research Article

Evaluation of a method for drug-related problems identification and classification in hospital setting: applicability and reliability

Research Article

Benefits, risks and impacts on quality of life of medications used in multimorbid older adults: a Delphi study

Research Article

Drug–drug interactions in patients undergoing chemoradiotherapy and the impact of an expert team intervention

Research Article

Potential drug–drug interactions associated with clinical and laboratory findings at hospital admission

Research Article

Impact of ‘Chief-Pharmacist System’ on drug expenditures and rational drug use

Research Article

The inappropriate use of proton pump inhibitors during admission and after discharge: a prospective cross-sectional study
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits